These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Silybin inhibits NLRP3 inflammasome assembly through the NAD Zhang B; Xu D; She L; Wang Z; Yang N; Sun R; Zhang Y; Yan C; Wei Q; Aa J; Liu B; Wang G; Xie Y FASEB J; 2018 Feb; 32(2):757-767. PubMed ID: 28970254 [TBL] [Abstract][Full Text] [Related]
3. ER stress induces NLRP3 inflammasome activation and hepatocyte death. Lebeaupin C; Proics E; de Bieville CH; Rousseau D; Bonnafous S; Patouraux S; Adam G; Lavallard VJ; Rovere C; Le Thuc O; Saint-Paul MC; Anty R; Schneck AS; Iannelli A; Gugenheim J; Tran A; Gual P; Bailly-Maitre B Cell Death Dis; 2015 Sep; 6(9):e1879. PubMed ID: 26355342 [TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation. Xu Y; Yang C; Zhang S; Li J; Xiao Q; Huang W Biol Pharm Bull; 2018 Nov; 41(11):1638-1644. PubMed ID: 30135326 [TBL] [Abstract][Full Text] [Related]
5. IRE1α inhibition decreased TXNIP/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic-ischemic brain injury in rats. Chen D; Dixon BJ; Doycheva DM; Li B; Zhang Y; Hu Q; He Y; Guo Z; Nowrangi D; Flores J; Filippov V; Zhang JH; Tang J J Neuroinflammation; 2018 Feb; 15(1):32. PubMed ID: 29394934 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development. He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273 [TBL] [Abstract][Full Text] [Related]
7. Bax Inhibitor-1 preserves pancreatic β-cell proteostasis by limiting proinsulin misfolding and programmed cell death. Blanc M; Habbouche L; Xiao P; Lebeaupin C; Janona M; Vaillant N; Irondelle M; Gilleron J; Murcy F; Rousseau D; Luci C; Barouillet T; Marchetti S; Lacas-Gervais S; Yvan-Charvet L; Gual P; Cardozo AK; Bailly-Maitre B Cell Death Dis; 2024 May; 15(5):334. PubMed ID: 38744890 [TBL] [Abstract][Full Text] [Related]
8. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2). Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625 [TBL] [Abstract][Full Text] [Related]
9. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation. Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185 [TBL] [Abstract][Full Text] [Related]
10. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation. Liu J; Wang T; He K; Xu M; Gong JP Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445 [TBL] [Abstract][Full Text] [Related]
11. IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis. Dasgupta D; Nakao Y; Mauer AS; Thompson JM; Sehrawat TS; Liao CY; Krishnan A; Lucien F; Guo Q; Liu M; Xue F; Fukushima M; Katsumi T; Bansal A; Pandey MK; Maiers JL; DeGrado T; Ibrahim SH; Revzin A; Pavelko KD; Barry MA; Kaufman RJ; Malhi H Gastroenterology; 2020 Oct; 159(4):1487-1503.e17. PubMed ID: 32574624 [TBL] [Abstract][Full Text] [Related]
12. Saturated Fatty Acids Engage an IRE1α-Dependent Pathway to Activate the NLRP3 Inflammasome in Myeloid Cells. Robblee MM; Kim CC; Porter Abate J; Valdearcos M; Sandlund KL; Shenoy MK; Volmer R; Iwawaki T; Koliwad SK Cell Rep; 2016 Mar; 14(11):2611-23. PubMed ID: 26971994 [TBL] [Abstract][Full Text] [Related]
13. Deletion of Perilipin 5 Protects Against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation. Asimakopoulou A; Engel KM; Gassler N; Bracht T; Sitek B; Buhl EM; Kalampoka S; Pinoé-Schmidt M; van Helden J; Schiller J; Weiskirchen R Cells; 2020 May; 9(6):. PubMed ID: 32481590 [TBL] [Abstract][Full Text] [Related]
14. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study. Mohamed IN; Sarhan NR; Eladl MA; El-Remessy AB; El-Sherbiny M Acta Histochem; 2018 Apr; 120(3):242-254. PubMed ID: 29482933 [TBL] [Abstract][Full Text] [Related]
15. FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury. Han CY; Rho HS; Kim A; Kim TH; Jang K; Jun DW; Kim JW; Kim B; Kim SG Cell Rep; 2018 Sep; 24(11):2985-2999. PubMed ID: 30208322 [TBL] [Abstract][Full Text] [Related]
16. Deficiency of the Purinergic Receptor 2X Blasetti Fantauzzi C; Menini S; Iacobini C; Rossi C; Santini E; Solini A; Pugliese G Oxid Med Cell Longev; 2017; 2017():8962458. PubMed ID: 29270247 [TBL] [Abstract][Full Text] [Related]
17. Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice. Zhang N; Lu Y; Shen X; Bao Y; Cheng J; Chen L; Li B; Zhang Q Pharmacology; 2015; 95(3-4):173-80. PubMed ID: 25896720 [TBL] [Abstract][Full Text] [Related]
18. Baicalin protects AML-12 cells from lipotoxicity via the suppression of ER stress and TXNIP/NLRP3 inflammasome activation. Zhang J; Zhang H; Deng X; Zhang Y; Xu K Chem Biol Interact; 2017 Dec; 278():189-196. PubMed ID: 29031535 [TBL] [Abstract][Full Text] [Related]
19. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis. Jiang S; Yan C; Fang QC; Shao ML; Zhang YL; Liu Y; Deng YP; Shan B; Liu JQ; Li HT; Yang L; Zhou J; Dai Z; Liu Y; Jia WP J Biol Chem; 2014 Oct; 289(43):29751-65. PubMed ID: 25170079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]